Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hectorol in Kidney Transplant Recipients
NCT00646282Phase 4Terminated
- Sponsor
- Emory University
- Start
- Apr 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxercalciferol in secondary hyperparathyroidism (SHPT), sponsored by Emory University. Started Apr 2008; status: terminated.
02
Drugs
doxercalciferol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00646282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00646282.